CoLumbo AI Spine MRI Analysis Software Receives FDA 510(k) Clearance for Version 3.0
CoLumbo Version 3 has received FDA 510(k) clearance, expanding its AI-powered spine MRI analysis capabilities to support cases involving scoliosis and fractures.
Smart Soft Healthcare is pleased to announce that CoLumbo Version 3, the latest version of its AI-powered spine MRI analysis software, has received FDA 510(k) clearance. This milestone reflects the company’s continued commitment to developing advanced AI solutions that support radiologists in spine MRI analysis and reporting.
Building on CoLumbo’s previous FDA clearance, Version 3 introduces support for DICOM images of patients with scoliosis and fractures. With these expanded capabilities, CoLumbo provides more comprehensive assistance in measuring and reporting spinal conditions, ensuring greater reliability for radiologists and improved outcomes for patients.
The latest clearance further strengthens CoLumbo’s role as an AI-powered solution for lumbar spine MRI analysis and expands the range of cases in which the software can support radiologists during image interpretation and reporting.
“Receiving the long-awaited FDA clearance for Version 3 of CoLumbo is a testament to our team’s relentless dedication to regulatory excellence. The new capabilities supporting scoliosis and fractures represent significant advancements that will enable us to better serve healthcare professionals and patients. We remain committed to maintaining the highest standards of safety, performance, and compliance as we continue to expand CoLumbo’s presence in the global market,” said Yoana Ivanova, Director of Regulatory Affairs at Smart Soft Healthcare.
Smart Soft Healthcare will continue to advance CoLumbo’s capabilities in response to the evolving needs of radiologists and the broader medical imaging community.
